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ABSTRACT
Measurements of lung function, including spirometry
and body plethesmography, are easy to perform and
are the current clinical standard for assessing disease
severity. However, these lung functional techniques do
not adequately explain the observed variability in clini-
cal manifestations of disease and offer little insight
into the relationship of lung structure and function.
Lung imaging and the image-based assessment of lung
disease hasmatured to the extent that it is common for
clinical, epidemiologic and genetic investigation to
have a component dedicated to image analysis. There
are several exciting imagingmodalities currently being
used for the non-invasive study of lung anatomy and
function. In this review, we will focus on two of them;
X-ray computed tomography and magnetic reso-
nance imaging. Following a brief introduction of each
method, we detail some of the most recent work being
done to characterize smoking-related lung disease and
the clinical applications of such knowledge.
Key words: asthma, chronic obstructive pulmonary
disease, emphysema, radiology and other imaging.
INTRODUCTION
Disease-related alterations in lung structure are
responsible for much of the functional limitations
observed in a variety of conditions such as asthma,
chronic obstructive pulmonary disease (COPD) and
interstitial lung disease. These structural changes are
the result of destruction or remodelling of the lung
parenchyma and airway wall. Remodelling is defined
as changes in the composition, content and organiza-
tion of the cellular and molecular constituents of the
lung tissue and contributes directly to changes in lung
elasticity and compliance aswell as airway narrowing.
The gold standard for the detection and quantifica-
tion of lung remodelling has always been histological
examination. Such studies have provided valuable
information on the processes and consequences of
lung remodelling but are limited because they require
access to surgical or autopsy samples and are neces-
sarily cross-sectional in design. Therefore, non-
invasive methods are required to further investigate
the pathogenesis of lung disease, to assess changes
over time and to allow the assessment of new thera-
peutic interventions designed to attenuate or reverse
these structural changes. Imaging techniques such as
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X-ray computed tomography (CT) andmagnetic reso-
nance imaging (MRI) allow for an in vivo assessment
of lung parenchyma as well as airway wall thickness
that is comparable to gross histological examination
(Fig. 1). However, the information that can be
obtained from CT lacks the detail of what can be
obtained from histology, and there are increasing
concerns over the health risks related to the ionizing
radiation necessary to acquire such images. Further-
more,MRI, while not limited by radiation risks, has its
own limitations in terms of tissue and spatial resolu-
tion. However, these imaging techniques are provid-
ing new information about lung structure and
function that have not been available before. The aim
of the current paper is to review the use of CT andMRI
in the investigation of lung structure and function in
health and disease, outlining the strengths and weak-
ness of both techniques.
CT OF LUNG PARENCHYMA
Emphysema
Smoking-related destruction of the lung parenchyma
is typically thought to manifest as emphysema and is
usually described as being centrilobular, panlobular
or paraseptal. Gough and Wentworth, subsequently
modified by Thurlbeck, described methods to quan-
tify the extent of the tissue destruction using fixed
slices of resected lungs. Obviously, while incredibly
important, assessments of lung destruction from
resected or post-mortem specimens do not provide
data that can help an individual patient. Therefore,
attention turned to roentologic studies of the lungs
of smokers which identified several cardinal signs
for the presence of emphysema such as increased
lucency of the lung fields, narrowing of the cardiac
silhouette and pruning of the peripheral vasculature.
Such findings are sensitive but lack the speci-
ficity required for large scale clinical and research
applications.
With the introduction of CT into themedicine in the
late 1970s, it became possible to visualize and display
lung structure in vivo in 3D with tissue structures
resolvedandappearingvery similar to grosspathology
images. Furthermore, because the CT image is really a
densitometric map of the lung, it is ideally suited to
quantitative assessments of emphysema. By compar-
ing the frequency distribution of the apparent X-ray
attenuation values to the extent of emphysema seen
on gross pathology, or the histologically measured
surface area of the lung, early investigators have found
that CT could be used to quantify emphysema.1–4
These studies showed that by either applying a thresh-
old cut-off of X-ray attenuation values, originally
termed Density Mask Analysis, the extent of emphy-
sema (densities less than a specific HU threshold)
could be quantified (Fig. 2).3–5 A second approach,
developed at the same time, has become known as the
percentile technique. Using this technique, the inves-
tigator chooses apoint on thepercentage scale, that is,
15th percentile, where the cumulative percentage of
the lung voxels are less than this cut-off (lowest 15th
percentile), and the corresponding X-ray attenuation
value (in HU) at that point is determined (Fig. 2b).
Early studies showed that the lowest 5th percentile
value correlated with the extent of emphysema1 and
surface area to volume ratio,2 while recent studies
show that the 15th percentile value serves as a mea-
surement of lung destruction.6,7 These two densito-
metric analyses of the lung parenchyma have become
Figure 1 Gross pathology and
computed tomography imaging.
Excised gross lung specimen (a) and
matched computed tomography
(CT) section of the same specimen
(b) from a subject undergoing lung
transplantation for severe emphy-
sema. These images clearly show
the severity of the emphysema
(arrow heads) and some airways cut
in cross section (arrows). These
images also illustrate that CT can
produce images that are very similar
to the actual lung seen in the gross
specimen. (Images provide courtesy
of Dr John McDonough, UBC James
Hogg Research Centre).
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the cornerstone of radiological characterization of
lung disease in smokers.
There have been numerous studies in the literature
that show that densitometric analysis is predictive of
clinically significant metrics such as lung function.8–13
However, longitudinal applications of these tech-
niques are more limited studies such as those by
Dirksen, and co-investigators show that the use of CT
will provide an analysis of change in lung density over
time that is more sensitive to intervention than the
usual analysis of change in lung function forced expi-
ratory volume in 1 s (FEV1).6 In fact, Dirksen and col-
leagues have shown that the 15th percentile
technique is able to show differential changes in lung
densitometry following pharmacologic intervention
with either alpha-1 antitrypsin augmentation7 or
treatment with steroids.14 They have also shown that
following smoking cessation, there is a decrease in
lung density, which on the surface appears to be the
opposite of the expected result, which they attribute
to a generalized loss of tissue density due to some
combination of reduced inflammatory response or
Figure 2 Quantitative computed tomography measurements of emphysema. These images illustrate the use of the
threshold and percentile techniques to quantify the extent of emphysema. The apparent X-ray attenuation values are
plotted as frequency distribution (a and b) and a shift in this distribution demonstrates a change in the air to tissue ratio
within the lung. Panel (a) shows the threshold technique where a pre-defined threshold of HU (i.e. -950 HU) is chosen,
and the percentage of lung less than this value is calculated. There is a greater percentage of the lung voxels beyond
the threshold in the dashed line subject than subject represented by the solid line. Similarly, the percentile technique
is illustrated in (b) where a certain percentile point (i.e. lowest 15th percentile) is chosen, and the HU values for that
percentile calculated. The HU value of the lowest 15th percentile is more negative (less dense) in the dashed line subject
than the solid line subject. Image (c) shows the CT voxels less than -950 HU in a transverse image, and (d) shows how
these low attenuation values are clustered using a three-dimensional reconstruction of the lung. CT, computed
tomography.
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reduction in other dense objects in the lung like soot
and tar.15 In another studyYuan et al. found that if the
lung density was expressed as a percentage of
maximal lung inflation, defined as predicted total
lung capacity divided by predicted lung weight, the
subjects with the greatest extent of over inflated lung
also showed the greatest decline in lung function over
time.16 These studies suggest that not only can CT
densitometry be used to follow disease pathogenesis
but that it can be used to monitor the response to
therapy with a greater level of precision than standard
lung functional measurements.
However, an important caveat to these methods is
that the appropriate HU threshold used to delineate
emphysematous from non-emphysematous tissue is
subject to the image acquisition and reconstruction
parameters.17–19 Furthermore, the lung volume at
which the CT scan is acquired will also play a large
role in the lung density. For these reasons a working
group of the Alpha-1 Foundation recommended that
while either the threshold technique or the percentile
technique can be used in cross-sectional studies, the
percentile technique, corrected for lung volume, is
the best metric to be used in longitudinal studies.20
However, both of these techniques are currently used,
and while the data for the percentile technique is very
strong, the threshold technique provides a value that
is often more meaningful in terms of understanding
how much emphysema is present in the lung and
allows localization and visualization of the low
attenuation regions (Fig. 2).
While densitometric analysis of the lung may
provide global, regional and lobar specific measures
of emphysema on CT scan, a major limitation is
its relative inability to differentiate emphysema
subtype (centrilobular, panlobular, etc.). In an effort
to address this, the community of radiologic and
computer scientists has focused on developing tech-
niques that may objectively identify emphysema type
and distribution. These are based largely on patterns
of local features in the secondary pulmonary lobule
and are often referred to as textural analysis.
Texture analysis of the lung involves the selection of
a discrete region of interest within the lung field and
then assessing several parameters in this constrained
region such as density and the patterns of changes in
density. The simplest textural approach is the fractal,
or cluster analysis, first used by Mishima.21 This
technique examines low attenuating voxels identified
using a threshold technique and quantifies them
according to how many are connected, or clustered,
together. This approach has been applied to CT data
acquired in clinical investigations such as those
involving lung volume reduction surgery,22,23 and
despite there being a weak correlation to histopathol-
ogy,24 it appears to more closely approximate a visual
analysis performed by a radiologist than standard
densitometry.25 More complex techniques have also
been developed and several groups of investigators
have demonstrated that this technique could accu-
rately identify disease type (using visual analysis as
a gold standard) and provide more robust mea-
sures of lung disease for correlation in clinical
investigation.26–29 Indeed, Xu et al. demonstrated that
such a technique could provide information that sur-
passed that provided by visual inspection.30While the
sensitivity of textural analysis is potentially superior
to visual inspection, it is computationally costly, and
until a more parsimonious approach to tissue classi-
fication is developed, it is limited to smaller scale
investigations.
Interstitial lung disease
The use of quantitative CT to measure lung structure
is not limited to regions of destroyed or hyperinflated
lung, but it can also be used to measure the increase
in lung tissue caused by fibrotic lung disease.
CT-based investigation in the 1980s and 1990s
focused on utilizing algorithms that examined the
histogram distributions of the lung density. For
example, Hartley et al. showed that frequency distri-
bution of the apparent X-ray attenuation values was
shifted towards denser lung in subjects with idio-
pathic pulmonary fibrosis and that this shift corre-
lated with functional changes and the presence of
macrophages and eosinophils in bronchoalveolar
lavage fluid.31 Coxson et al. demonstrated that CT
could be used to measure a decrease in air volume
and a corresponding increase in tissue volume in
idiopathic pulmonary fibrosis without actually
changing the total lung mass.32 However, the draw-
back of these studies is that they do not provide a
robust method to discriminate early disease from
dense fibrosis or to provide a useful method to follow
disease longitudinally. A major challenge for intersti-
tial lung disease has been that, unlike emphysema,
fibrotic lung disease lacks a standard HU threshold
that can dichotomize the visualized lung tissue into
normal and disease.
Another confounding issue with using CT to quan-
tify tissue changes in fibrotic lung disease is that
chronic tobacco smoke exposure has been linked to
the development of both COPD and idiopathic pul-
monary fibrosis. Furthermore, recent investigation
suggests that the co-occurrence of the radiologic
manifestations of these processes may be found in up
to 10% of smokers.33 The pathway of disease progres-
sion in such individuals is unknown, and while it may
diverge to amore restrictive or obstructive physiology,
more detailed study of this overlap may provide
insight into the factors associated with the develop-
ment of end stage COPD and idiopathic pulmonary
fibrosis. Therefore, it is increasingly clear that algo-
rithms focused on tissue classification will have to
integrate techniques that detect both emphysema
and high attenuating interstitial lung disease.
For these reasons, recent investigation has focused
on advanced texture based algorithms that have
the potential to quantify the changes in lung den-
sitometry and have the ability to discriminate visual
patterns similar to assessment by a trained radiolo-
gist.34,35 However, there are multiple challenges fac-
ing such approaches including the computational
expense of such algorithms, the need to isolate the
parenchyma from the airways and vessels prior to
performing an analysis (normal high attenuating
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structures can be misclassified as disease) and the
presence of a large volume of high quality data that
can be used to develop and validate such an algo-
rithm. Despite these hurdles, several groups have
made exciting progress in this area, and it is now real-
istic to anticipate robust software applications that
may detect and quantify normal tissue as well as that
exhibiting honeycombing, reticular and ground glass
patterns of disease.
Asthma
Asthma is a disease of the airways and until recently
has not been the focus of densitometric analysis.
Attention has recently turned to using expiratory
CT scans and a threshold technique to quantify the
extent of ‘gas trapping’ that is present. It is thought
that this could be a useful surrogate for small airway
disease below the spatial resolution of the CT scanner.
A recent study from the Severe Asthma Research
Program showed that the extent of gas trapping mea-
sured using lung densitometry was associated with
increased hospitalization, and those with the most
severe gas trapping were also those most likely to
need treatment in the intensive care unit.36
CT OF AIRWAYS
The other major focus of lung structure—function
relationships is the airway. Because of their spatial
resolution, CT scans seemed well positioned to
become the method of choice to non-invasively
measure airway wall dimensions (Fig. 3). Early
studies focused on manual tracing of the airway wall,
but since this technique was susceptible to variations
caused by the display features of the CT images or
inter and intra observer variability, attention quickly
changed to automated airway analysis. In the inter-
vening years, there have been numerous studies
designed to develop and implement automated
airway analysis algorithms.37–40 Many of these studies
were used simple analysis such as the ‘full-width at
half maximum’ algorithm,8,11,38,41,42 but others have
used more complex model-based approaches.37,39,40
While many convincing arguments have been made
about the superiority of themodel-based approaches,
the full width at half maximum is still commonly
used. However, a major drawback to all airway
research is that there is still no consensus about the
appropriate algorithm to use which limits compari-
son of results between centres.
The common parameters obtained from airway
measurements are similar to those obtainedusinghis-
tology.Theseparameters include: total bronchial area,
or outer airway wall area (Ao), the wall area (WA), the
internal, or lumen, area (Ai), and the wall thickness
(WT) (Fig. 4). All of these measurements were origi-
nally obtained by random or arbitrary selection of
airways cut in cross-section on the transverse CT
images.While this is a reasonablemethod formeasur-
ing airways, and has roots in histologic sampling of
airways, investigators still needed to normalize the
airway measurements so that comparisons between
subjects couldbeperformed. Initially, thiswas accom-
plished by calculating a value known as the wall area
percent (WA%: 100 * (wall area)/(lumen + wall area) ).
However, there is an inherent ‘reference trap’ in the
WA% measurements where WA% increases as total
bronchial area decreases irrespective of changes in
WA. Previous histology studies have shown that the
square root of the airwayWAwas linearly related to the
internal perimeter (Pi) of the airway. Therefore, inves-
tigatorshave found thatbyplotting thePi of all airways
measured on CT against the square root of WA on a
subject by subject basis, the resulting regression equa-
tion canbeused topredict the square root ofWA for an
arbitrary airway with an internal perimeter of 10 mm
(Pi10). This Pi10 value is proving to be a reliable stan-
dardized measurement of airway wall size that can be
Figure 3 Computed tomographic
images of airways. This figure
shows two transverse computed
tomography (CT) images of the left
lung. The airways in image (a) seem
to be thinner than the airways in
image (b) suggesting that the CT
scans can be used to quantify airway
wall changes.
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used to compare airway wall measurements between
subjects.
In one of the first systematic analysis of airwaymor-
phology in smokers, Nakano et al. assessed the apical
segment of the right upper lobe in 114 smokers. In
their analysis, they observed that those subjects with
the greatest WA% (increased ratio of wall area to
lumen area) had the lowest FEV1 expressed as a
percent of predicted.11 Based upon this investigation,
the WA% has become the most commonly employed
metric for clinical investigation largely because it has
consistently provided the strongest correlation to
spirometric measures of lung function. In a subse-
quent investigation, this same group demonstrated
that central airway remodelling apparent on CT
reflected distal histopathologic remodelling of the
small airways, those with great central airway wall
thickening had more small airway disease.43
Recently, with the advent and proliferation of
multi-detector row CT scanners, airway analysis has
switched to ‘volumetric’ analysis, whereby the entire
bronchial tree is reconstructed and then the airway
wall dimensions obtained at the midpoint between
two branch points using multi-planar reformatted
images.40,44 This was also thought to be advantageous,
because it would allow only more peripheral airways
to bemeasured, whichmay produce a stronger corre-
lation with lung function. In fact, studies have shown
that measurements of the fifth and sixth generation
of the airway tree have better correlation with lung
function than do more central airways.20,44 It is also
thought that this approach will give better mea-
surements of the airway dimensions, because it
allows for a segment by segment comparison between
individuals.
While these findings have compelled investigators
to examine more and more distal airways, such mea-
sures are limited by the resolution of the CT images.
Therefore, some investigators have turned their
attention to densitometry measurements of expira-
tory CT scans. It is thought that if there is small airway
remodelling, it causes ‘gas trapping’ on expiration,
which can be quantified using a threshold analysis
and a cut-off set very close to the theoretical X-ray
attenuation value that represents maximal lung infla-
tion, that is, total lung capacity divided by lung mass.
These studies, especially in asthma, have shown that
these measurements of ‘gas trapping’ do correlate
with clinical symptoms in severe asthmatics and in
response to therapy.36,45
Investigators have also begun to look beyond
airway wall thickening to assess airway disease in
smokers. Included in these efforts are quantitative
assessments of mural density or attenuation.46 The
premise behind these investigations is that as an
airway wall thickens or remodels, both the shape and
contents of the wall change. Normal bronchial carti-
lage may be gained or lost, and normal connective
tissue is replaced by scar. Preliminary investigation
suggests that airway wall attenuation may provide
additional information regarding airway disease in
smokers.46 Further work is needed to comprehen-
sively understand the scanner to scanner variability
and the influence of body habitus on these measures.
Recently, Hogg et al. introduced a new paradigm
for airway disease in smokers. Not only does airway
remodelling lead to obstruction of the small airways
and expiratory airflow obstruction, but there appears
to be an outright loss of airways in advanced COPD.47
Based upon these findings, Diaz et al. examined the
chest CT scans of 50 smokers enrolled in the Lung
Tissue Research Consortium and found that those
subjects with more advanced emphysema have
pruning of the central airways on CT scan (loss of
airways in generations 5–8).48 Further, even after
adjustment for densitometric measures of emphy-
sema, the total airway count (sum of airway genera-
tions visible in the third to eighth generation starting
fromtheapical segmentof the rightupper lobe)wasan
independent predictor of the BODE score, which is a
validated multidimensional measure of mortality in
COPD. Further histologic validation is needed to
determine the extent towhich airway lossmanifests in
the more proximal airway tree; however, airway drop
out may be a marker of the extreme of airway disease.
CT OF THE PULMONARY
VASCULATURE
Pulmonary vascular disease is an independent
predictor of morbidity and mortality in COPD, and
Figure 4 Airway measurements.
This figure shows a cartoon repre-
sentation (image on the left) of the
airway wall with the parameters
measured from the airway indicated.
These parameters are also noted
in the expanded image of the com-
puted tomography (CT) airway wall.
The CT measurements are obtained
using the full width at half maximum
principle. Pi =&thinsp internal peri-
meter of the airway wall. Ai =
internal lumen area of the airway.
WA = wall area. TBA = total bron-
chial area (wall and lumen).
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pathologic pulmonary vascular remodelling is found
even in smokers with normal lung function.49–52 The
mechanisms for this process likely include inflamma-
tion in milder COPD with hypoxic vasoconstriction
and outright loss of parallel pathways due to emphy-
sematous destruction of the tissue in more severe
disease. While the standard visual assessment of
pulmonary vascular remodelling includes measure-
ments of the diameter of the main pulmonary artery,
more recent investigations have demonstrated that
remodelling of the distal intra-parenchymal pulmo-
nary vasculature yields compelling insights into the
relation of vascular disease and emphysema, its rela-
tion to pulmonary artery pressure and a potential
link between pulmonary vascular remodelling and
atherosclerotic disease as assessed by thoracic aortic
calcification.53
In an attempt to assess pulmonary vascular remod-
elling at its earliest stages, Alford et al. undertook an
investigation using central venous boluses of iodi-
nated contrast agent.54 In a cohort of 43 subjects (17
normals, 12 smokers with no emphysema and normal
lung function, 12 smokers with very mild emphy-
sema), they demonstrated that changes in the pulmo-
nary vasculature could be detected and quantitatively
assessed at its very earliest stages.54 While such an
approach is not amenable to population-based
studies, these data may suggest that emphysemamay
begin as a vascular disease leading to a regional loss of
tissue.
EMERGING RESEARCH APPLICATIONS
OF CT
Advances in image processing and large-scale appli-
cation of CT scanning in clinical investigation have
led to compelling new insight into the clinical and
physiologic impact of COPD. In the population-
basedMulti Ethnic Study of Atherosclerosis, Barr et al.
clearly demonstrated that emphysema and its associ-
ated hyperinflation compromises cardiac function
through reductions in left ventricular filling, possibly
due to occult pulmonary vascular remodelling.55
More recently, Han and colleagues depicted the very
complex relationship between radiologic emphy-
sema, airway disease and acute exacerbations of
COPD.56 The results of this investigation may allow
clinicians and researchers to identify who is at great-
est risk for an acute exacerbations of COPD andmaxi-
mize preventive therapies for such events and enrich
clinical studies for subsequent investigation. Finally,
CT imaging has become an essential part of mini-
mally invasive lung volume reduction procedures
such as the placement of one-way valves. These
studies have shown that device placement can result
in an overall decrease in lung volume20 and that
incomplete interlobar fissures mitigate procedural
benefit likely due to collateral ventilation.57
While these results are exciting, and it is through
such investigation that new therapies and therapeutic
approaches to care will be discovered, these advances
don’t come without concern. The clinical and
research community is increasingly aware of the risks
associated with the radiation exposure necessary for
CT acquisition. The estimates of the associations
between the dose of radiation and risk of cancer vary
and may be as high as 1/80 lifetime risk from a single
CT.58 These risks will not preclude the use of CT
imaging, but the clinical and research community
must always weigh this concern with the potential
benefit of having such data.
MRI
Application to thoracic imaging
Tissue contrast in conventional MRI stems from
the perturbation of water- and fat-bound hydrogen
atoms (otherwise known as protons (1H)) using a
burst of radio-frequency energy. When the patient is
in the ‘magnet’, they take with them the billions of
protons that are randomly spinning in various direc-
tions in the body, but when placed in the scanner,
protons line up parallel and anti-parallel to the strong
magnetic field of the scanner. The MRI signal that we
see derives from the tiny net fraction of protons (1 or
2/million) that are aligned with the magnetic field of
the scanner and after application of radio-frequency
radiation, these undergo realignment that is detected
and converted into the image.
Conventional 1H MRI is readily available in most
radiology departments, however until now, a number
of fundamental challenges have limited its useful-
ness for lung imaging. Exquisite soft tissue three-
dimensional contrast of most organs in the body is
achieved via the detection of water-bound protons in
slightly different chemical environments. This con-
trast is dependent on the proton density of the tissues
being examined, and unfortunately the lung has rela-
tively low tissue density and therefore low proton
density. This is one reason why thoracic MRI, even
when optimized for the lung, results in images59,60 that
resemble black holes, with the lung regions mainly
devoid of contrast, tissue and morphological infor-
mation. Compounding this, the lung architecture
consists of millions of air-tissue interfaces on the
micrometer scale. The juxtaposition of the different
magnetic environments related to the tightly spaced
air and tissue compartments result in so-called mag-
netic ‘susceptibility artifacts’ that accelerate signal
decay. Taken together, low proton density and suscep-
tibility artefacts mean that conventional pulmonary
1H MRI must incorporate both short echo times and
long acquisition times. For these reasons, the devel-
opment of conventional thoracic MRI has been
mainly overlooked as a clinical application, although
its diagnostic potential was recognized by Mayo and
Müller over two decades ago.61
Recently, there has been a renewed interest in
the clinical potential of thoracic MRI stimulated by
cardiac MRI developments,62 by novel pulmonary
functional MRI using noble gas contrast agents63
as well as oxygen-enhanced64 and Fourier-
decomposition proton MRI65,66 of the lung. While
recent reviews of oxygen-enhanced proton MRI67,68
and noble gas MRI63 have recently been published,
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here we focus on novel lung functional MRI using
noble gases and their comparison to CT in acknowl-
edgement of the unprecedented opportunity these
methods provide for respiratory medicine.
Structure—function MRI of the
lung parenchyma
The promise of pulmonary functional MRI was first
recognized over 15 years ago with the landmark dis-
covery of Albert and colleagues.69 Imaging typically
takes place with the subject in breath-hold, 10–15 s
after inhalation of a discrete volume of magnetized
(or hyperpolarized) helium or xenon gas. As shown in
Figure 5, for hyperpolarized lung functional MRI,
imaging provides a way to estimate inhaled gas distri-
bution in healthy young and older never smokers, and
in subjects with asthma, COPD, cystic fibrosis and
radiation-induced lung injury. These images provide
a way to regionally describe and quantify those areas
of the lung that appear to participate in gas distribu-
tion and those that do not. In healthy young adults, a
single inhalation of hyperpolarized 3He gas results in
homogeneous signal (Fig. 5) suggesting that all areas
of the lung are participating equally in gas distribu-
tion (for the purposes of this review, we will use the
term ventilation and gas distribution interchange-
ably). In contrast, characteristic volumetric ‘focal’
ventilation defects are observed in COPD, asthma,
cystic fibrosis, radiation-induced lung injury and sur-
prisingly, even in otherwise healthy elderly never
smokers70,71 as regions that do not appear to contain
gas signal. Focal ventilation defects are thought to
correspond to areas of the lung that are not ventilated
or perhaps poorly ventilated within the time course of
a typical 10–15 s breath-hold scan,72 but the exact eti-
Figure 5 Hyperpolarized 3He magnetic resonance imaging. Hyperpolarized 3He MRI coronal centre slice images for
healthy young and old never smokers and subjects with asthma, chronic obstructive pulmonary disease (COPD),
radiation-induced lung injury (RILI) and cystic fibrosis (CF). In young never-smokers, 3He gas distribution (shown in red)
is homogeneous, but in the elderly never smokers and subjects with respiratory disease, characteristic focal defects are
clearly visible and can be measured qualitatively and quantitatively.
Healthy young never smoker: 26-year-old female, FEV1 = 95%, FEV1/FVC = 90%
Asthma: 48-year-old female FEV1 = 67%, FEV1/FVC = 65%
COPD: 72-year-old male FEV1 49%, FEV1/FVC = 54%
Elderly never smoker: 73-year-old male FEV1 = 104%, FEV1/FVC = 78%
RILI: 55-year-old male FEV1 = 54%, FEV1/FVC = 73%
CF: 21-year-old male FEV1 = 74%, FEV1/FVC = 71%.
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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ology of these functional abnormalities in relation to
airway and parenchyma structural abnormalities has
not yet been determined.
Based on our current understanding of the strong
relationship between lung structure and function, it is
generally assumed that when lung tissue and mor-
phology appear normal on X-ray-based images, lung
function is also likely normal and vice versa. Hyper-
polarized 3He MRI has the advantage in that it pro-
vides simultaneous structure—function information,
and this unique ability has been used to test these
assumptions. For example, as previously described71
and shown in another COPDpatient in Figure 6, when
3He MRI functional ventilation images of a patient
with GOLD stage 3 COPD are directly compared with
CT images, there is no anatomical or tissue heteroge-
neity detected in the CT images that would be pre-
dictive of the apparent functional abnormalities
(especially note the lack of function in the left upper
lobes) revealed by 3He MRI. This suggests that MRI
provides important functional information not pro-
vided by CT and furthermore challenges our assump-
tions of lung function based on CT lung structural
findings. Focal 3He gas distribution abnormalities
can be directly quantified as the 3He MRI ventilation
defect volume,71 or as the normalized ventilation
defect percent73,74 and percent ventilation volume,75
all of which have excellent reproducibility.73 It is
important to note that all these functional measure-
ments of the parenchyma depend on gas flow through
the airways, thereby enabling an indirect measure-
ment of airway patency and function.76
Another important property of noble gas MRI that
provides a unique non-invasive way to measure lung
microstructure is their small size (relative to inhaled
aerosolized or nebulized drug therapy) and corre-
sponding high self-diffusion rates. MR methods can
be used that are sensitive to gas self-diffusion, and
these provide a measure of gas displacement in the
lung that is dependent on random Brownian motion
(as opposed to transmembrane gas diffusion). The
apparent diffusion coefficient of inhaled gas can be
derived, reflecting the apparent decreased displace-
ment of the gas when inhaled and restricted by the
airways and airspaces. For example, for diffusion
times on the order of milliseconds, the average
displacement of helium atoms by virtue of its self-
diffusion is the same order of magnitude as alveolar
diameters (a few hundred micrometers), and there-
fore these measurements are sensitive to differences
in alveolar sizes. As shown in Figures 6 and 7, 3He
and 129Xe apparent diffusion coefficient provide a sur-
rogate measurement of airspace size and accordingly
of emphysematous damage77–79 and gas trapping,80
strongly correlating with diffusing capacity of carbon
monoxide81 and histological measurements of lung
surface area.82,83 As shown in Figure 7, the 3He or 129Xe
apparent diffusion coefficient image can be interro-
gated on a pixel-by-pixel basis to provide a quantita-
tive apparent diffusion coefficient map depicts
Figure 6 Computed tomography
and 3He magnetic resonance
imaging (MRI) centre coronal slices
for a 71-yr-old female with stage III
chronic obstructive pulmonary
disease (forced expiratory volume
in 1 s (FEV1) = 47%pred, FEV1/forced
vital capacity = 41%, diffusing capac-
ity of carbon monoxide = 31%pred).
(a) Centre slice coronal reconstruc-
tion MDCT (GE 64 slice) in grey-
scale. (b) Centre slice coronal 1H MRI
thoracic cavity in grey scale with
co-registered hyperpolarized 3He
MRI static ventilation image in red.
(c) Hounsfield unit threshold of
-950HU in red shown over MDCT
centre coronal slice. (d) Hyperpolar-
ized 3He MRI apparent diffusion
coefficient map generated from
diffusion-weighted imaging (b =
1.6 s/cm2).
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emphysematous destruction in those regions of the
lung participating in ventilation. 129Xenon MRI has
the added advantage of being freely diffusible across
the alveolar capillary membrane, and simultaneous
imaging of the gas in the alveolus, in the alveolar wall
and blood is now possible84 opening up new opportu-
nities for understanding ventilation-perfusion abnor-
malities in respiratory disease. Importantly, as shown
in Figure 7, the functional images provided by 3He
and 129Xe are qualitatively and quantitatively indistin-
guishable, which given the limited availability and
high cost of 3He gas63 bodes well for the clinical and
research translation of 129Xe MRI in future. It is also
possible to exploit the accelerated gas signal decay in
the presence of oxygen in the lung by measuring the
differential rates of decay of 3He or 129Xe85,86 related to
heterogeneity in oxygen partial pressures, providing
an in vivo window on the most fundamental aspect
of lung function. Finally, the use of noble gas MRI
in longitudinal and treatment studies provides
new windows on our understanding of smoking-
related disease. Recent work has shown the sensitive
and accelerated detection of COPD progression in
ex-smokers over a 2-year period as compared to
standard spirometry and plethysmography mea-
surements that showed no change.87 In addition,
dramatic improvements in gas distribution post-
bronchodilator were shown88 in COPD ex-smokers
even in subjects with modest or no apparent FEV1
measured response, further evidence of the power of
this method when applied in treatment studies.
Structure-function MRI of airways
One technological advantage of thoracicMRI is that it
may be used to dynamically interrogate gas flow and
delivery via the airways.89–92 Such measurements may
reflect regions with either airway or parenchymal
abnormalities, or potentially an admixture of the two.
Figure 7 Hyperpolarized 3He and 129Xe magnetic resonance imaging (MRI) and CT in a female subject with stage II
chronic obstructive pulmonary disease (forced expiratory volume in 1 s (FEV1) = 52%pred, FEV1/forced vital vapac-
ity = 42%, diffusing capacity of carbon monoxide = 18%pred). (a) Centre slice coronal reconstruction MDCT (GE 64 slice)
in grey scale. (b) Centre slice coronal 1H MRI thoracic cavity in grey scale with co-registered hyperpolarized 3He MRI
static ventilation in red. (c) Centre slice coronal 1H MRI thoracic cavity in grey scale with co-registered hyperpolarized
129Xe MRI static ventilation in blue. (d) Hounsfield unit threshold of -950HU in red shown over MDCT centre coronal
slice. (e) Hyperpolarized 3He MRI apparent diffusion coefficient map generated from diffusion-weighted imaging
(b = 1.6 s/cm2). (f) Hyperpolarized 129Xe MRI apparent diffusion coefficient map generated from diffusion-weighted
imaging (b = 30 s/cm2).
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Importantly, dynamic measurements are not depen-
dent on the proximal airway structure for measure-
ments of distal airway remodelling but provide more
direct measurements of the distal small airways.
Dynamic imaging can be performed as a wash-in or
wash-out procedure, showing the filling and empty-
ing of the lung in respiratory disease. The clinical
potential of this approach is yet to be exploited, but
certainly the measurements provided can be used to
test hypotheses related to underlying disease mecha-
nisms in asthma, COPD and cystic fibrosis.
SUMMARY AND CONCLUSIONS
CT andMRI are maturing technologies that have pro-
vided new insight into the remodelling of the airways,
parenchyma and the pulmonary vasculature. The
strength of CT lies in its speed, availability and its
technical ability to provide highly detailed measures
of lung structure, whileMRI provides insight into lung
function on the macro and microscopic level. While
good agreement between MRI and CT pulmonary
findings has been previously reported, it is clear that
lung imaging using MRI currently cannot surpass
high-resolution CT in terms of speed, image contrast
and content as well as spatial resolution. In fact,
because of the inherent limitations based on the
physics of MRI itself, pulmonary MRI may never
replace high-resolution CT for lung disease diagnosis
and monitoring. However, in recognition of the fact
that the lung is the most radiosensitive organ in the
chest,93,94 and longitudinal monitoring will increase
the risk of cumulative radiation doses,95 especially in
children, MRI, even conventional 1H MRI, should be
considered. The information derived is certainly
complementary to CT and in some longitudinal
applications in chronic disease is superior to CT
because of its relatively low-risk and high-lung func-
tion information content. These and other techniques
will continue to improve understanding of disease
pathophysiology and may ultimately improve the
care of patients with COPD.
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